Depending on provider evaluation, eligible patients may discuss Tirzepatide, Semaglutide, Mounjaro, Zepbound, Wegovy, Ozempic, lifestyle support, medication education, and follow-up care as part of a customized medical weight loss plan
Upregulation of mitochondrial NAD(+) levels impairs the clonogenicity of SSEA1(+) glioblastoma tumor-initiating cells
Rekkers ME, Aardenburg L, Scheffers M, van Elburg AA, van Busschbach JT (2022) Shifting the focus: a pilot study on the effects of positive body exposure on body satisfaction, body attitude, eating pathology and depressive symptoms in female patients with eating disorders
Sinha R, Sinha I, Calcagnotto A, et al
52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA